<DOC>
	<DOCNO>NCT01940913</DOCNO>
	<brief_summary>To assess tolerability effect probiotic product , co-administered antibiotic , incidence duration loose/watery stool follow antibiotic treatment child .</brief_summary>
	<brief_title>Efficacy Safety Probiotic Product Children With Antibiotic-associated Gastrointestinal Disorders .</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion 1 . Children age 111 year ordinate start antibiotic treatment except penicillin . 2 . Possibility initiate probiotic treatment within 24 hour first dose antibiotic treatment . 3 . Children whose parent legal caregiver sign informed consent participate study . Exclusion criteria 1 . Chronic intestinal disease . 2 . Current immunodeficiency immunosuppressive treatment . 3 . Chronic acute diarrhoeal disease . 4 . Use laxatives week inclusion study . 5 . Antibiotic treatment last four week inclusion study . 6 . Known hypersensitivity ingredient probiotic product placebo [ potato starch , silicon dioxide , capsule ( hypromellose , water ) ± bacterial culture ] . 7 . Intake probiotic product last two week inclusion study . 8 . Patient require hospitalisation . Lack parents´/legal guardians´ inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>